A detailed history of Forefront Wealth Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Forefront Wealth Partners, LLC holds 653 shares of LLY stock, worth $493,387. This represents 0.37% of its overall portfolio holdings.

Number of Shares
653
Previous 548 19.16%
Holding current value
$493,387
Previous $423 Million 27.49%
% of portfolio
0.37%
Previous 0.32%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$725.72 - $929.72 $76,200 - $97,620
105 Added 19.16%
653 $539 Million
Q4 2024

May 14, 2025

BUY
$727.2 - $932.06 $398,505 - $510,768
548 New
548 $423 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $718B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Forefront Wealth Partners, LLC Portfolio

Follow Forefront Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Wealth Partners, LLC with notifications on news.